Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the filing of a New Drug Submission (NDS) with Health Canada's Therapeutic Products Directorate (TPD) seeking Canadian approval of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback